A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer (Q33435705)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer |
scientific article |
Statements
1 reference
A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer (English)
1 reference
Alberto A Chiappori
1 reference
Gregory A Otterson
1 reference
Afshin Dowlati
1 reference
Anne M Traynor
1 reference
Leora Horn
1 reference
Taofeek K Owonikoko
1 reference
Helen J Ross
1 reference
Christine L Hann
1 reference
Jorge Nieva
1 reference
Xiuhua Zhao
1 reference
Michael Schell
1 reference
Daniel M Sullivan
1 reference
30 September 2016
1 reference
1 reference
21
1 reference
10
1 reference
1163-1164
1 reference
Identifiers
1 reference
1 reference
1 reference